Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Doctoral Training Network on Glycan–Cancer–Microbiota Interactions for Therapeutic and Diagnostic Innovation in Colorectal cancer

Ziel

Colorectal cancer (CRC) remains a major global health challenge, and increasing evidence shows that gut microbiota plays a decisive role in tumour progression and immune escape. Yet, the molecular rules governing communication between tumour cells, microbes and the immune system remain unknown. GlyCaBiota DN addresses this critical gap by focusing on how tumour and microbial glycans and proteins that recognize them shape CRC biology. Our innovative programme places glycan-mediated interactions at the core of the tumour–microbiota–immune axis, enabling the rational development of next-generation diagnostic and therapeutic strategies. By combining structural, cellular and computational approaches, GlyCaBiota will decode the molecular mechanisms driving microbial colonisation, immune modulation and CRC progression. Our consortium brings together leading experts in glycoscience, microbiology, cancer biology and immunology, structural biology, bioinformatics and translational research. With nine academic and five industrial partners, one oncology center and an international network, GlyCaBiota provides complementary expertise, unique tools and clinical connections to train 15 doctoral candidates (DCs). The combination of excellent interdisciplinary science, industry know-how and clinical perspective covers the entire pipeline from fundamental discoveries to innovative solutions. DCs will gain cutting-edge scientific and transferable skills, positioning them for impactful careers across academia, industry and healthcare. GlyCaBiota will create a critical mass of researchers capable of integrating glycoscience and microbiome research to tackle key challenges in CRC. By deciphering glycan-mediated interactions, GlyCaBiota will expand fundamental knowledge and strengthen European innovation capacity, enabling future development of precision diagnostics and therapeutic strategies for CRC.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral Networks

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-MSCA-2025-DN-01

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

UNIVERSIDADE NOVA DE LISBOA
Netto-EU-Beitrag
€ 838 335,96
Adresse
CAMPUS DE CAMPOLIDE
1099-085 Lisboa
Portugal
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
Keine Daten

Beteiligte (11)

Partner (8)